US FDA inspects Vishakhapatnam facility of Solara Active Pharma

US Food and Drug Administration (US FDA) has successfully completed the inspection of the multipurpose API...

Sun Pharma, SPARC sign licence agreement for sale of seizure drug

SPARC submitted a new drug application (NDA) to the US Food and Drug Administration (US FDA) for this product for...

Indian pharma compliance standards improving, regulatory...

Mumbai (Maharashtra) [India], July 7 (ANI): Indian pharmaceutical companies have built a strong abbreviated new drug...

US FDA issues warning letter for Glenmark Pharmaceuticals...

Mumbai (Maharashtra) [India], Oct 7 (ANI): The US Food and Drug Administration (US FDA) has issued a warning letter...

US FDA issues warning letter for Lupin's Mandideep facility

Mumbai (Maharashtra) [India], Sep 19 (ANI): The US Food and Drug Administration (US FDA) has issued a warning letter...